IL6 and Increased total leukocyte count: By downregulating Th17 cells, ISM inhibits the production of Il-6 and reduces the expression of adhesion molecules in endothelial cells, consequently decreasing monocyte migration to the inflammation sites, alleviating the proliferation of endothelial and rheumatoid-like cells and leukocytosis, ultimately eliminating foot swelling in CIA rats.